Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Eris Lifesciences has informed that a meeting of the Board of Directors is scheduled to be held on Saturday, 3rd November, 2018 to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / half year ended 30th September, 2018.Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on “code of conduct to regulate, monitor and report trading by Insiders” of the Company, the Trading Window for dealing in shares of the Company will remain closed from 26th October, 2018 to 5th November, 2018 for the purpose of this board meeting.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: